| Primary |
| Parkinson's Disease |
53.6% |
| Parkinsonism |
9.2% |
| Influenza |
4.6% |
| Depression |
3.9% |
| Anxiety Disorder |
3.3% |
| Multiple Sclerosis |
3.3% |
| Tremor |
3.3% |
| Fatigue |
2.6% |
| Nasopharyngitis |
2.6% |
| Schizophrenia |
2.0% |
| Supranuclear Palsy |
2.0% |
| Altered State Of Consciousness |
1.3% |
| Amnesia |
1.3% |
| Cerebral Infarction |
1.3% |
| Convulsion |
1.3% |
| Hypertension |
1.3% |
| Listless |
1.3% |
| Angina Pectoris |
0.7% |
| Asthenia |
0.7% |
| B-cell Lymphoma |
0.7% |
|
| Tremor |
9.3% |
| Serotonin Syndrome |
7.4% |
| Toxic Encephalopathy |
7.4% |
| Corneal Oedema |
5.6% |
| Hallucination |
5.6% |
| Hallucination, Visual |
5.6% |
| Oedema Peripheral |
5.6% |
| Somnolence |
5.6% |
| Urinary Tract Infection |
5.6% |
| Vomiting |
5.6% |
| Confusional State |
3.7% |
| Dystonia |
3.7% |
| Insomnia |
3.7% |
| Pulmonary Oedema |
3.7% |
| Rhabdomyolysis |
3.7% |
| Status Epilepticus |
3.7% |
| Syncope |
3.7% |
| Thrombocytopenia |
3.7% |
| Treatment Noncompliance |
3.7% |
| Vision Blurred |
3.7% |
|
| Secondary |
| Parkinson's Disease |
45.9% |
| Drug Use For Unknown Indication |
13.1% |
| Depression |
4.4% |
| Psychotic Disorder |
4.3% |
| Hepatitis C |
4.1% |
| Product Used For Unknown Indication |
3.7% |
| Multiple Sclerosis |
2.6% |
| Tremor |
2.5% |
| Fatigue |
2.4% |
| Influenza |
2.4% |
| Drug Therapy |
2.1% |
| Hypertension |
1.7% |
| Parkinsonism |
1.7% |
| Nutritional Support |
1.6% |
| Dyskinesia |
1.5% |
| Rabies |
1.5% |
| Convulsion |
1.3% |
| Antiviral Treatment |
1.2% |
| Hypothyroidism |
1.2% |
| Suicide Attempt |
1.2% |
|
| Tremor |
13.5% |
| Corneal Oedema |
9.9% |
| Psychotic Disorder |
9.2% |
| Completed Suicide |
8.5% |
| Death |
5.7% |
| Somnolence |
5.7% |
| Platelet Count Decreased |
5.0% |
| Rhabdomyolysis |
4.3% |
| Vertigo |
4.3% |
| Hallucinations, Mixed |
3.5% |
| Syncope |
3.5% |
| Urinary Tract Infection |
3.5% |
| Vomiting |
3.5% |
| Cerebrovascular Accident |
2.8% |
| Dyskinesia |
2.8% |
| Facial Palsy |
2.8% |
| Hallucination |
2.8% |
| Hypotonia |
2.8% |
| Myoclonus |
2.8% |
| No Adverse Event |
2.8% |
|
| Concomitant |
| Parkinson's Disease |
25.2% |
| Multiple Sclerosis |
19.3% |
| Product Used For Unknown Indication |
10.6% |
| Drug Use For Unknown Indication |
7.8% |
| Depression |
5.4% |
| Hypertension |
5.0% |
| Fatigue |
4.4% |
| Pain |
3.8% |
| Relapsing-remitting Multiple Sclerosis |
2.7% |
| Insomnia |
2.0% |
| Anxiety |
1.9% |
| Parkinsonism |
1.8% |
| Prophylaxis |
1.7% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Osteoporosis |
1.3% |
| Headache |
1.3% |
| Schizophrenia |
1.3% |
| Multiple System Atrophy |
1.1% |
| Neuralgia |
1.0% |
| Asthma |
1.0% |
|
| Tremor |
9.0% |
| Weight Decreased |
9.0% |
| Pathological Gambling |
8.8% |
| Urinary Tract Infection |
8.1% |
| Weight Increased |
7.5% |
| Suicidal Ideation |
5.3% |
| Somnolence |
5.1% |
| Multiple Sclerosis Relapse |
5.0% |
| Parkinson's Disease |
4.2% |
| Pneumonia |
4.2% |
| Vomiting |
4.0% |
| Progressive Multifocal Leukoencephalopathy |
3.7% |
| Wound Infection Staphylococcal |
3.7% |
| White Blood Cell Count Decreased |
3.5% |
| Pain |
3.3% |
| Convulsion |
3.1% |
| Dizziness |
3.1% |
| Pyrexia |
3.1% |
| Syncope |
3.1% |
| Death |
2.9% |
|
| Interacting |
| Epilepsy |
29.8% |
| Parkinson's Disease |
19.1% |
| Drug Use For Unknown Indication |
17.0% |
| Depression |
4.3% |
| Dyskinesia |
4.3% |
| Gait Disturbance |
4.3% |
| Initial Insomnia |
4.3% |
| Motor Dysfunction |
4.3% |
| Muscle Rigidity |
4.3% |
| B-cell Lymphoma |
2.1% |
| Routine Health Maintenance |
2.1% |
| Schizophrenia |
2.1% |
| Tardive Dyskinesia |
2.1% |
|
| Tremor |
50.0% |
| Drug Interaction |
12.5% |
| Malaise |
12.5% |
| Serotonin Syndrome |
12.5% |
| Weight Increased |
12.5% |
|
